ERBB4 and urinary bladder carcinoma: In patients with bladder cancer, the combined HER4/NRG4 signaling unit can be growth inhibitory, and the co-expression of HER4 together with NRG4 is highly correlated to better survival if the two proteins act together rather than individually [28].